Free Trial

Aigen Investment Management LP Takes $1.50 Million Position in Dolby Laboratories, Inc. (NYSE:DLB)

Dolby Laboratories logo with Consumer Discretionary background

Aigen Investment Management LP purchased a new stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 19,640 shares of the electronics maker's stock, valued at approximately $1,503,000.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Dolby Laboratories by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 6,502,463 shares of the electronics maker's stock valued at $544,711,000 after purchasing an additional 107,713 shares during the last quarter. Ninety One UK Ltd boosted its holdings in Dolby Laboratories by 2.6% in the 2nd quarter. Ninety One UK Ltd now owns 2,344,963 shares of the electronics maker's stock worth $185,791,000 after buying an additional 60,114 shares during the period. Disciplined Growth Investors Inc. MN raised its position in Dolby Laboratories by 0.8% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 1,402,623 shares of the electronics maker's stock worth $111,130,000 after purchasing an additional 10,852 shares during the period. Boston Trust Walden Corp raised its holdings in shares of Dolby Laboratories by 185.3% in the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker's stock worth $82,276,000 after buying an additional 698,283 shares during the last quarter. Finally, Mackenzie Financial Corp grew its position in shares of Dolby Laboratories by 3.5% in the second quarter. Mackenzie Financial Corp now owns 1,010,230 shares of the electronics maker's stock valued at $80,041,000 after purchasing an additional 33,848 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 28,512 shares of the company's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total value of $2,113,309.44. Following the transaction, the chief executive officer now owns 83,721 shares of the company's stock, valued at approximately $6,205,400.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 39.54% of the company's stock.

Analyst Ratings Changes

DLB has been the subject of a number of analyst reports. StockNews.com raised Dolby Laboratories from a "buy" rating to a "strong-buy" rating in a report on Friday. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 20th.

View Our Latest Stock Report on Dolby Laboratories

Dolby Laboratories Price Performance

DLB traded down $1.55 during trading on Tuesday, hitting $73.92. 317,802 shares of the stock traded hands, compared to its average volume of 396,147. The firm has a 50-day moving average of $73.35 and a 200 day moving average of $76.30. Dolby Laboratories, Inc. has a 12-month low of $66.35 and a 12-month high of $90.06. The firm has a market capitalization of $7.05 billion, a P/E ratio of 34.34 and a beta of 0.98.

Dolby Laboratories announced that its board has initiated a share repurchase plan on Wednesday, August 7th that permits the company to buyback $350.00 million in outstanding shares. This buyback authorization permits the electronics maker to purchase up to 5% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

See Also

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should you invest $1,000 in Dolby Laboratories right now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines